Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells

Jaegyu Hwang1, Long Tai Zheng, Jiyeon Ock

  • 1Department of Pharmacology, School of Medicine, Brain Science and Engineering Institute, CMRI, Kyungpook National University, Daegu, South Korea.

Insights

m-Chlorophenylpiperazine (m-CPP) reduces neuroinflammation by decreasing pro-inflammatory factors in glia cells. This drug also demonstrated neuroprotective effects, suggesting potential for treating neuroinflammatory diseases.

Area of Science:

  • Neuroscience
  • Neuroinflammation
  • Pharmacology

Background:

  • Glia cells, including microglia and astrocytes, mediate neuroinflammation and are implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
  • m-Chlorophenylpiperazine (m-CPP) is a drug that affects serotonergic function via 5-HT1 and 5-HT2 receptors, but its anti-inflammatory mechanisms are unclear.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of m-CPP in lipopolysaccharide (LPS)-stimulated microglia and astrocyte cultures.
  • To elucidate the molecular mechanisms underlying m-CPP's anti-inflammatory actions.
  • To assess the neuroprotective potential of m-CPP in a microglia-neuron co-culture model.

Main Methods:

  • Primary cell cultures of microglia and astrocytes were stimulated with LPS.
  • Treatment with m-CPP was applied to assess its impact on nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) production.
  • Gene expression of inducible nitric oxide synthase (iNOS) and pro-inflammatory cytokines was analyzed.
  • Nuclear factor-kappa B (NF-kappa B) activation and p38 mitogen-activated protein kinase (MAPK) phosphorylation were assessed.
  • A microglia-neuron co-culture system was used to evaluate neuroprotection.

Main Results:

  • m-CPP significantly reduced the production of NO, TNF-alpha, and IL-1beta in LPS-stimulated microglia and astrocytes.
  • m-CPP attenuated the mRNA expression of iNOS, IL-1beta, and TNF-alpha.
  • m-CPP inhibited NF-kappa B activation and p38 MAPK phosphorylation in LPS-stimulated microglia.
  • m-CPP demonstrated neuroprotective effects by reducing microglia-mediated neuroblastoma cell death.

Conclusions:

  • m-CPP exhibits significant anti-inflammatory effects in microglia and astrocytes.
  • The anti-inflammatory actions of m-CPP are mediated through the inhibition of NF-kappa B and p38 MAPK pathways.
  • m-CPP possesses neuroprotective properties, suggesting its therapeutic potential for neuroinflammatory conditions.